TY - JOUR T1 - Interference with the lower gut–liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis JF - BMJ Open Gastroenterology DO - 10.1136/bmjgast-2018-000239 VL - 5 IS - 1 SP - e000239 AU - John Ong AU - Leila Mebarek AU - Michael Bath AU - Carla Swift AU - Babur Javaid AU - Jenish Patel AU - Yasseen Al-Naeeb Y1 - 2018/11/01 UR - http://bmjopengastro.bmj.com//content/5/1/e000239.abstract N2 - The gut–liver axis describes the complex interactions between gut microbiota, the small and large bowel, the immune system and the liver. Current evidence associates abnormalities within the gut–liver axis with liver disease such as primary sclerosing cholangitis (PSC). PSC is believed to be an immune-mediated disease though the exact mechanism of its pathogenesis remains unknown. Here, we report a case of a 66 -year-old woman with treatment-resistant ulcerative colitis and PSC which continued to be active following subtotal colectomy. Interestingly, her PSC achieved full remission after proctectomy for treatment-resistant proctitis in the rectal stump. This case report supports existing hypotheses that PSC is an immune-mediated disease triggered by antigens within the gut. More notably, it suggests the yet unidentified pathogens may be localised to the lower gastrointestinal tract including the rectum. ER -